Dr. Nagarajan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2950 Cleveland Clinic Blvd
Weston, FL 33331Phone+1 954-659-5840Fax+1 954-659-5833
Summary
- I am board certified in Internal Medicine, Medical Oncology and Hematology
Education & Training
University of Arkansas for Medical SciencesFellowship, Hematology and Medical Oncology, 2001 - 2004
West Suburban Medical CenterResidency, Internal Medicine, 1999 - 2001
Rush University Medical CenterInternship, Internal Medicine, 1998 - 1999
Adichunchanagiri Institute of Medical SciencesClass of 1996
Certifications & Licensure
FL State Medical License 2015 - 2026
WV State Medical License 2004 - 2017
IL State Medical License 2000 - 2005- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI Start of enrollment: 2013 May 31
- Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) Start of enrollment: 2015 Nov 19
Publications & Presentations
PubMed
- 103 citationsEvaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion.Elena M. Stoffel, Shannon E. McKernin, Randall E. Brand, Marcia I. Canto, Michael Goggins
Journal of Clinical Oncology. 2019-01-10 - 61 citationsImmunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline.Manish A Shah, Erin B Kennedy, Ashley E Alarcon-Rozas, Thierry Alcindor, Angela N Bartley
Journal of Clinical Oncology. 2023-03-01 - 17 citationsPractical and cost-effective model to build and sustain a cardio-oncology programDiego Sadler, Chakra P Chaulagain, Beatrice Alvarado, Robert Cubeddu, Elizabeth Stone
Cardio-Oncology. 2020-07-16
Journal Articles
- E3611- A Randomized Phase II Study of Ipilimumab at 3 or 10 mg/kg Alone or in Combination with High Dose Interferon-α2b in Advanced MelanomaArun Nagarajan, Mark R Albertini, Stuart Wong, Noel Laudi, Robert M Conry, Clinical Cancer Research
Committees
- Hereditary Pancreatic cancer PCO panel, ASCO 2016 - Present
Research History
- Co-Principal Investigator for ECOG trials at Charleston Area Medical Center2004 - 2016
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
